BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23331559)

  • 1. The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma.
    Kent SE; Boyce M; Diamant Z; Singh D; O'Connor BJ; Saggu PS; Norris V
    Clin Exp Allergy; 2013 Feb; 43(2):177-86. PubMed ID: 23331559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils.
    Chaudhuri R; Norris V; Kelly K; Zhu CQ; Ambery C; Lafferty J; Cameron E; Thomson NC
    Pulm Pharmacol Ther; 2014 Feb; 27(1):62-9. PubMed ID: 24333186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study.
    Follows RM; Snowise NG; Ho SY; Ambery CL; Smart K; McQuade BA
    Respir Res; 2013 May; 14(1):54. PubMed ID: 23682661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
    Kent SE; Bentley JH; Miller D; Sterling R; Menendez R; Tarpay M; Pearlman DS; Norris V
    Allergy Asthma Proc; 2014; 35(2):126-33. PubMed ID: 24717789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study.
    Singh D; Boyce M; Norris V; Kent SE; Bentley JH
    Int J Gen Med; 2013; 6():897-903. PubMed ID: 24357936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The allergen specificity of the late asthmatic reaction.
    Hatzivlassiou M; Grainge C; Kehagia V; Lau L; Howarth PH
    Allergy; 2010 Mar; 65(3):355-8. PubMed ID: 19804443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
    Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
    Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual CysLT
    Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
    Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients.
    Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Costa F; Vagaggini B; Paggiaro PL
    Ann Allergy Asthma Immunol; 2008 May; 100(5):457-62. PubMed ID: 18517078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor.
    Bain G; King CD; Schaab K; Rewolinski M; Norris V; Ambery C; Bentley J; Yamada M; Santini AM; van de Wetering de Rooij J; Stock N; Zunic J; Hutchinson JH; Evans JF
    Br J Clin Pharmacol; 2013 Mar; 75(3):779-90. PubMed ID: 22803688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
    Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
    Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
    Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum levels of reduced glutathione increase 24 hours after allergen challenge in isolated early, but not dual asthmatic responders.
    Beier J; Beeh KM; Semmler D; Buhl R
    Int Arch Allergy Immunol; 2004 Sep; 135(1):30-5. PubMed ID: 15286443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
    Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
    Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens.
    Boulet LP; Gauvreau G; Boulay ME; O'Byrne PM; Cockcroft DW
    Clin Exp Allergy; 2015 Nov; 45(11):1647-53. PubMed ID: 26115509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.